1. Home
  2. APGE vs DXPE Comparison

APGE vs DXPE Comparison

Compare APGE & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • DXPE
  • Stock Information
  • Founded
  • APGE 2022
  • DXPE 1908
  • Country
  • APGE United States
  • DXPE United States
  • Employees
  • APGE N/A
  • DXPE N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • DXPE Industrial Machinery/Components
  • Sector
  • APGE Health Care
  • DXPE Industrials
  • Exchange
  • APGE Nasdaq
  • DXPE Nasdaq
  • Market Cap
  • APGE 2.4B
  • DXPE 1.9B
  • IPO Year
  • APGE 2023
  • DXPE 1996
  • Fundamental
  • Price
  • APGE $66.64
  • DXPE $88.41
  • Analyst Decision
  • APGE Strong Buy
  • DXPE Buy
  • Analyst Count
  • APGE 9
  • DXPE 1
  • Target Price
  • APGE $97.33
  • DXPE $95.00
  • AVG Volume (30 Days)
  • APGE 730.3K
  • DXPE 218.6K
  • Earning Date
  • APGE 11-10-2025
  • DXPE 11-06-2025
  • Dividend Yield
  • APGE N/A
  • DXPE N/A
  • EPS Growth
  • APGE N/A
  • DXPE 36.17
  • EPS
  • APGE N/A
  • DXPE 5.27
  • Revenue
  • APGE N/A
  • DXPE $1,959,889,000.00
  • Revenue This Year
  • APGE N/A
  • DXPE $10.99
  • Revenue Next Year
  • APGE N/A
  • DXPE $6.65
  • P/E Ratio
  • APGE N/A
  • DXPE $16.86
  • Revenue Growth
  • APGE N/A
  • DXPE 12.76
  • 52 Week Low
  • APGE $26.20
  • DXPE $67.68
  • 52 Week High
  • APGE $67.66
  • DXPE $130.97
  • Technical
  • Relative Strength Index (RSI)
  • APGE 73.22
  • DXPE 31.64
  • Support Level
  • APGE $61.81
  • DXPE $84.04
  • Resistance Level
  • APGE $67.66
  • DXPE $100.59
  • Average True Range (ATR)
  • APGE 3.73
  • DXPE 6.07
  • MACD
  • APGE 0.19
  • DXPE -1.69
  • Stochastic Oscillator
  • APGE 91.78
  • DXPE 11.33

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.

Share on Social Networks: